Zongmin Zhao
@zongmin_zhao
Followers
1K
Following
3K
Media
8
Statuses
465
Assistant Professor @UICPharm @uicpsci at University of Illinois Chicago. Drug delivery, immunoengineering, cellular engineering. Associate Editor @BioTM_Buzz.
Chicago, IL
Joined June 2017
RT @UICscience: Relay runners depend on one another to pass the baton. 🏃. @thisisUIC researchers created a relay process in the body’s immu….
0
5
0
Honored to receive this award for work on a new therapeutic approach for autoimmune diseases. Looking forward to more translational explorations.
Dr. Zongmin Zhao was awarded a Chancellor’s Translational Research Initiative award from the Office of the Vice Chancellor for Innovation and the Office of Technology Management. Congratulations!
7
0
21
This work was led by PhD student Chih-Jia Chao. Very thankful to our amazing collaborators @pengzhangphd, Yu Gao, Steve Lee, and Joanna Burdette.
0
0
3
Happy to share our new work in @NatureComms. We report ACT-DC, a nanoparticle-boosted dendritic cell therapy that turns tumor into an effective vaccination site for in situ immunization.
9
4
27
RT @UICancerCenter: Cancer Center members are among the authors of the study, “Correlative Multiscale 3D Imaging of Mouse Primary and Metas….
0
2
0
RT @nanoscale_rsc: We're delighted to present our 2024 Emerging Investigators and showcase articles from these incredible rising stars in n….
0
28
0
RT @Dr_ASingh: 🚨Hiring Alert! Please RT!.My lab is anticipating new multi-year funding. We have multiple postdoc positions available in bui….
0
59
0
RT @UICPharm: PhD student Chih-Jia Chao received the Government Scholarship to Study Abroad (GSSA) from the Ministry of Education of Taiwan….
0
1
0
Thrilled to share that we have received a new R21 award from @theNCI. In collaboration with the Er and Lee labs, we will develop a new cell-based delivery tool for targeted modulation of key mechanobiological pathways in metastatic breast cancer.
4
0
48
Great to see the work led by Chih-Jia Chao receiving this recognition. Look forward to advancing this project for more translational explorations.
Three #UICPharm researchers were granted a Chancellor's Translational Research Initiative (CTRI) award. The CTRI program provides financial support for early-stage projects for licensing and startup opportunities. Today we're celebrating Dr. Zongmin Zhao. Congratulations!
8
1
27
RT @KoladeAdebowal1: New manuscript! Excited to contribute to the 'Hydrogels in the Clinic' series in @BioTM_Buzz with @SMitragotri, @JohnR….
0
12
0
RT @NPeppas: This wonderful review reminded how I started at MIT in 1971. How much has changed in "Hemostats in the clinic" by Maithili Jo….
0
5
0
RT @MaithiliJoshi_: Excited to share our review on hemostatic agents, where we summarize trends in 54 approved hemostats and 75 active clin….
0
6
0
RT @WyattShieldsIV: What happens to immune cells in our lungs during dives? 🤿 Check out the answer in our newest paper @BioTM_Buzz! Thanks….
0
4
0
RT @nanoscale_rsc: Zongmin Zhao @zongmin_zhao has been selected as one of our 2024 Nanoscale Emerging Investigators! Congratulations on the….
0
6
0
RT @JulieNguyenLab: @zongmin_zhao and colleagues discuss the engineering of cells for precision drug delivery. In their review, they cover….
0
1
0
RT @JulieNguyenLab: One issue is not sufficient to cover all the amazing #EmergingVoices @ADDReditors! Here is Issue 2, co-edited w/ @Shawn….
0
13
0
RT @AinslieLab: Our paper is out in print today in @BioTM_Buzz! Immunogenicity of an adjuvanted broadly active influenza vaccine in immuno….
0
7
0
RT @Abhi_Immuneng: Our lab has an open position for a postdoctoral scholar in #immunoengineering field. Pls RT 🙏.
0
20
0
Check out our review discussing considerations for nanoparticle design for in vivo hitchhiking to cells. This work was led by 2nd-year PhD student Edidiong Udofa.
ADDR 50 days' free access: In situ cellular hitchhiking of nanoparticles for drug delivery. By Edidiong Udofa & Zongmin Zhao @UICPharm.#CellBasedDelivery #InSitu .
1
2
32